We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc

Delisted

ARNA was delisted on the 10th of March, 2022.

121 hedge funds and large institutions have $245M invested in Arena Pharmaceuticals Inc in 2015 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 36 increasing their positions, 35 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more call options, than puts

Call options by funds: $3.07M | Put options by funds: $1.97M

11% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 19

3% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 35

1% more funds holding

Funds holding: 120121 (+1)

8% less capital invested

Capital invested by funds: $267M → $245M (-$21.5M)

Holders
121
Holders Change
+1
Holders Change %
+0.83%
% of All Funds
3.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
21
Increased
36
Reduced
35
Closed
19
Calls
$3.07M
Puts
$1.97M
Net Calls
+$1.1M
Net Calls Change
-$94K

ARNA Hedge Fund Activity: Q4 2015 in Review

121 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q4 2015, worth a combined $245M — down 8.1% from $267M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new ARNA positions and 19 closed out — a net gain of 2 holders — while 36 added to existing stakes and 35 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $17.8M. The largest seller was Wellington Management Group, cutting an estimated $18.1M.

  • 121 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q4 2015, up from 120 in Q3 2015.
  • Funds reported $245M of Arena Pharmaceuticals Inc stock for Q4 2015, down 8.1% quarter-over-quarter.
  • 21 funds opened new Arena Pharmaceuticals Inc positions in Q4 2015 and 19 closed out, a net change of +2 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q4 2015 was RA Capital Management, an estimated $17.8M added.
  • The largest Arena Pharmaceuticals Inc seller in Q4 2015 was Wellington Management Group, an estimated $18.1M sold.

Based on aggregated 13F filings for Q4 2015.